Cargando…

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation

BACKGROUND: The magnitude of increased risk of stroke in women with atrial fibrillation (AF) remains uncertain. HYPOTHESIS: We investigated the risk of ischemic stroke and death in women and men with AF, and the risk associated with individual non‐sex CHA(2)DS(2)‐VASc risk factors. METHODS: Retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomasdottir, Maria, Friberg, Leif, Hijazi, Ziad, Lindbäck, Johan, Oldgren, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788468/
https://www.ncbi.nlm.nih.gov/pubmed/31490011
http://dx.doi.org/10.1002/clc.23257
_version_ 1783458496602177536
author Tomasdottir, Maria
Friberg, Leif
Hijazi, Ziad
Lindbäck, Johan
Oldgren, Jonas
author_facet Tomasdottir, Maria
Friberg, Leif
Hijazi, Ziad
Lindbäck, Johan
Oldgren, Jonas
author_sort Tomasdottir, Maria
collection PubMed
description BACKGROUND: The magnitude of increased risk of stroke in women with atrial fibrillation (AF) remains uncertain. HYPOTHESIS: We investigated the risk of ischemic stroke and death in women and men with AF, and the risk associated with individual non‐sex CHA(2)DS(2)‐VASc risk factors. METHODS: Retrospective cohort study of 231 077 (48.1% women) nonselected patients with AF not receiving oral anticoagulation from 2006 to 2014. Data from cross‐linked national Swedish registers. The outcome was the first occurrence of ischemic stroke or death. Median age was 82 and 75 years in women and men, respectively. Mean follow‐up was 2.5 years. RESULTS: Hazard ratios, adjusted for non‐sex CHA(2)DS(2)‐VASc risk factors, for women vs men were 1.53, 95% CI: 1.49‐1.58 for ischemic stroke and 1.24, 95% CI: 1.22‐1.26 for death, respectively. When divided into age groups the differences in ischemic stroke rates between women and men were attenuated. In patients with only one non‐sex CHA(2)DS(2)‐VASc risk factor allotted 1 point, ischemic stroke rates per 100 person‐years were 1.22 in women (n = 9838) and 1.02 in men (n = 15 609), respectively, P < .006. In both women and men, age of 65 to 74 years was associated with higher ischemic stroke risk compared to other non‐sex CHA(2)DS(2)‐VASc risk factors allotted 1 point. CONCLUSIONS: The risk of ischemic stroke was 1.5‐fold higher in women compared to men but this association appears to be the result of confounding by age. In the low risk end, the CHA(2)DS(2)‐VASc risk score underestimates the ischemic stroke risk conferred by age 65 to 74 years, while it overestimates the risk conferred by female sex.
format Online
Article
Text
id pubmed-6788468
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-67884682019-10-18 Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation Tomasdottir, Maria Friberg, Leif Hijazi, Ziad Lindbäck, Johan Oldgren, Jonas Clin Cardiol Clinical Investigations BACKGROUND: The magnitude of increased risk of stroke in women with atrial fibrillation (AF) remains uncertain. HYPOTHESIS: We investigated the risk of ischemic stroke and death in women and men with AF, and the risk associated with individual non‐sex CHA(2)DS(2)‐VASc risk factors. METHODS: Retrospective cohort study of 231 077 (48.1% women) nonselected patients with AF not receiving oral anticoagulation from 2006 to 2014. Data from cross‐linked national Swedish registers. The outcome was the first occurrence of ischemic stroke or death. Median age was 82 and 75 years in women and men, respectively. Mean follow‐up was 2.5 years. RESULTS: Hazard ratios, adjusted for non‐sex CHA(2)DS(2)‐VASc risk factors, for women vs men were 1.53, 95% CI: 1.49‐1.58 for ischemic stroke and 1.24, 95% CI: 1.22‐1.26 for death, respectively. When divided into age groups the differences in ischemic stroke rates between women and men were attenuated. In patients with only one non‐sex CHA(2)DS(2)‐VASc risk factor allotted 1 point, ischemic stroke rates per 100 person‐years were 1.22 in women (n = 9838) and 1.02 in men (n = 15 609), respectively, P < .006. In both women and men, age of 65 to 74 years was associated with higher ischemic stroke risk compared to other non‐sex CHA(2)DS(2)‐VASc risk factors allotted 1 point. CONCLUSIONS: The risk of ischemic stroke was 1.5‐fold higher in women compared to men but this association appears to be the result of confounding by age. In the low risk end, the CHA(2)DS(2)‐VASc risk score underestimates the ischemic stroke risk conferred by age 65 to 74 years, while it overestimates the risk conferred by female sex. Wiley Periodicals, Inc. 2019-09-06 /pmc/articles/PMC6788468/ /pubmed/31490011 http://dx.doi.org/10.1002/clc.23257 Text en © 2019 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigations
Tomasdottir, Maria
Friberg, Leif
Hijazi, Ziad
Lindbäck, Johan
Oldgren, Jonas
Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
title Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
title_full Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
title_fullStr Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
title_full_unstemmed Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
title_short Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
title_sort risk of ischemic stroke and utility of cha(2)ds(2)‐vasc score in women and men with atrial fibrillation
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788468/
https://www.ncbi.nlm.nih.gov/pubmed/31490011
http://dx.doi.org/10.1002/clc.23257
work_keys_str_mv AT tomasdottirmaria riskofischemicstrokeandutilityofcha2ds2vascscoreinwomenandmenwithatrialfibrillation
AT fribergleif riskofischemicstrokeandutilityofcha2ds2vascscoreinwomenandmenwithatrialfibrillation
AT hijaziziad riskofischemicstrokeandutilityofcha2ds2vascscoreinwomenandmenwithatrialfibrillation
AT lindbackjohan riskofischemicstrokeandutilityofcha2ds2vascscoreinwomenandmenwithatrialfibrillation
AT oldgrenjonas riskofischemicstrokeandutilityofcha2ds2vascscoreinwomenandmenwithatrialfibrillation